Search

Author/Creator Colevas, A Dimitrios

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy. (26th March 2019)

Authors:
Le, Quynh Thu; Colevas, A Dimitrios; O'Sullivan, Brian; Lee, Anne W M; Lee, Nancy; Ma, Brigette; Siu, Lillian L; Waldron, John; Lim, Chwee-Ming; Riaz, Nadeem; Lynn, Jean; Malik, Shakun
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 7(2019)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy. (8th November 2018)

Authors:
Chen, Y -P; Wang, Y -Q; Lv, J -W; Li, Y -Q; Chua, M L K; Le, Q -T; Lee, N; Colevas, A Dimitrios; Seiwert, T; Hayes, D N; Riaz, N; Vermorken, J B; O'Sullivan, B; He, Q -M; Yang, X -J; Tang, L -L; Mao, Y -P; Sun, Y; Liu, N; Ma, J
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141. (15th February 2022)

Authors:
Gillison, Maura L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara...
Journal:
Oncologist
Issue:
Volume 27:Number 2(2022)
Page Start:
e194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Issue 8 (August 2017)

Authors:
Harrington, Kevin J; Ferris, Robert L; Blumenschein, George; Colevas, A Dimitrios; Fayette, Jérôme; Licitra, Lisa; Kasper, Stefan; Even, Caroline; Vokes, Everett E; Worden, Francis; Saba, Nabil F; Kiyota, Naomi; Haddad, Robert; Tahara, Makoto; Grünwald, Viktor; Shaw, James W; Monga, Manish; Lynch...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 8(2017:Aug.)
Page Start:
1104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Issue 10166 (5th January 2019)

Authors:
Gillison, Maura L; Trotti, Andy M; Harris, Jonathan; Eisbruch, Avraham; Harari, Paul M; Adelstein, David J; Jordan, Richard C K; Zhao, Weiqiang; Sturgis, Erich M; Burtness, Barbara; Ridge, John A; Ringash, Jolie; Galvin, James; Yao, Min; Koyfman, Shlomo A; Blakaj, Dukagjin M; Razaq, Mohammed A; C...
Journal:
Lancet
Issue:
Volume 393:Issue 10166(2019)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Issue 10166 (5th January 2019)

Authors:
Gillison, Maura L; Trotti, Andy M; Harris, Jonathan; Eisbruch, Avraham; Harari, Paul M; Adelstein, David J; Sturgis, Erich M; Burtness, Barbara; Ridge, John A; Ringash, Jolie; Galvin, James; Yao, Min; Koyfman, Shlomo A; Blakaj, Dukagjin M; Razaq, Mohammed A; Colevas, A Dimitrios; Beitler, Jonatha...
Journal:
Lancet
Issue:
Volume 393:Issue 10166(2019)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗